Open access · OA
via Europe PMC
The NAD<sup>+</sup> challenge: Harnessing immune-mediated tumor control without fueling the enemy.
Molecular therapy. Oncology · 2026
Abstract
This 2026 Molecular Therapy Oncology article examines the role of NAD+ metabolism in regulating immune responses and tumor progression.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1016/j.omton.2026.201311
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
E, Z., EA, H., & ME., L. (2026). The NAD<sup>+</sup> challenge: Harnessing immune-mediated tumor control without fueling the enemy. <em>Molecular therapy. Oncology</em>. https://doi.org/10.1016/j.omton.2026.201311
Vancouver
E Z, EA H, ME. L. The NAD<sup>+</sup> challenge: Harnessing immune-mediated tumor control without fueling the enemy. Molecular therapy. Oncology. 2026. doi:10.1016/j.omton.2026.201311.
BibTeX
@article{zuiker2026TheNAD,
title = {The NAD<sup>+</sup> challenge: Harnessing immune-mediated tumor control without fueling the enemy.},
author = {Zuiker E and Hemann EA and Long ME.},
journal = {Molecular therapy. Oncology},
year = {2026},
doi = {10.1016/j.omton.2026.201311},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
GeroScience 2023
Preprint · OA
Blazing a trail for the clinical use of rapamycin as a geroprotecTOR
Bioorganic & medicinal chemistry 2026
Citation only
Emerging chemical strategies for CD38 inhibition: restoring NAD<sup>+</sup> metabolism and disease control.
Ageing Research Reviews 2022
Citation only
CXCL12/CXCR4: An amazing challenge and opportunity in the fight against fibrosis
Alzheimer's & dementia : the journal of the Alzheimer's Association 2026
Open access · OA
NAD<sup>+</sup>‒circadian rhythm coupling in dementia.
Cell Metabolism 2018
Open access · OA
Circadian Control of DRP1 Activity Regulates Mitochondrial Dynamics and Bioenergetics
Seminars in Cell and Developmental Biology 2024
Open access · CC-BY